Latest From TheraVasc Inc.
At a time when venture capital dollars are scarce and US-based innovation is threatened, Cleveland Clinic Innovations, with its novel GCIC cardiovascular project, is bringing critical mass and a new direction to an inherently unwieldy process.
- Therapeutic Areas
- Metabolic Disorders
- Wound Healing & Tissue Repair
- North America
- Parent & Subsidiaries
- TheraVasc Inc.
- Senior Management
Tony Giordano, PhD, Pres. & CEO
Robert Kovelman, PhD, Dir., Lead Discovery
- Contact Info
Phone: (318) 349-3851
11000 Cedar Ave., BioEnterprise
Cleveland, OH 44106
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.